Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 10/20 | 0.46 |
| ▸ | DRD2 | P14416 | 10/20 | 0.46 |
| ▸ | DRD4 | P21917 | 10/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.46 |
| ▸ | CNR2 | P34972 | 1/20 | 0.45 |
| ▸ | IRAK4 | Q9NWZ3 | 5/20 | 0.40 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.37 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30730146 | 0.79 | HTR1A (0.45) | HTR1ADRD2DRD4KCNH2CNR2 | |
| SCHEMBL23006094 | 0.78 | HTR1A (0.44) | HTR1ADRD2DRD4KCNH2CNR2 | |
| SCHEMBL27393779 | 0.75 | HTR1A (0.42) | HTR1ADRD2DRD4KCNH2CNR2 | |
| SCHEMBL27393509 | 0.75 | HTR1A (0.42) | HTR1ADRD2DRD4KCNH2CNR2 | |
| SCHEMBL27283960 | 0.75 | HTR1A (0.44) | HTR1ADRD2DRD4KCNH2CNR2 | |
| SCHEMBL27393504 | 0.74 | HTR1A (0.43) | HTR1ADRD2DRD4KCNH2CNR2 | |
| SCHEMBL27266356 | 0.73 | HTR1A (0.41) | HTR1ADRD2DRD4KCNH2CNR2 | |
| SCHEMBL27283961 | 0.72 | HTR1A (0.44) | HTR1ADRD2DRD4KCNH2CNR2 | |
| SCHEMBL30730115 | 0.72 | CNR2 (0.46) | HTR1ADRD2DRD4KCNH2CNR2 | |
| SCHEMBL2540851 | 0.72 | HTR1A (0.43) | HTR1ADRD2DRD4KCNH2CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4562015-A2 | CDK2 INHIBITORS AND METHODS OF USING THE SAME | Cedilla Therapeutics, Inc. (US) | 2025-06-04 | — | — | EP | disclosed |
| WO-2024026481-A2 | CDK2 INHIBITORS AND METHODS OF USING THE SAME | CEDILLA THERAPEUTICS, INC. (US) | 2024-02-01 | — | — | WO | disclosed |